全球非处方止痛药市场：依药物类别、给药途径、剂型、通路及地区划分

全球非处方止痛药市场规模预计将从 2024 年的 271.2 亿美元增至 2031 年的 355 亿美元，2024 年至 2031 年复合年增长率为 3.9%。

图：2024 年非处方止痛药市占率（按地区划分）

由于关节炎、下背痛和其他肌肉骨骼疾病等健康状况的盛行率不断上升，全球非处方止痛药市场在过去十年中出现了显着增长。容易取得的非处方笺止痛药以及人们越来越倾向于自我治疗而不是看医生正在推动市场成长。此外，已开发国家人口老化，更容易受到慢性疼痛的影响，需求也增加。各种製药公司正在透过推出功效更高、副作用最小的新产品来开拓利润丰厚的前景。

市场动态：

全球非处方止痛药市场的主要驱动力是老年人口的增加、文明病患者数量的增加以及不需要即时医疗干预的轻伤和不适症状的数量增加。然而，特别是在已开发国家，围绕自我治疗的法律规范非常严格，为企业的顺利运作带来了挑战。此外，替代传统止痛疗法的可用性也在一定程度上阻碍了市场的成长。同时，发展中地区健康意识的提高和电子商务的普及正在开拓新的收益来源。此外，先进药物输送系统的持续研究和开发正在为市场创造新的机会。

本研究的主要特点

该报告对全球非处方止痛药市场进行了详细分析，并以2023年为基准年估计了预测期内（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）发布了。

它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

基于公司亮点、产品系列、主要亮点、财务表现和策略等参数的全球非处方止痛药市场的主要企业概况。

主要企业包括强生、辉瑞、拜耳、GlaxoSmithKline Plc、大正製药和雀巢。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球非处方止痛市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球非处方止痛市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球非处方止痛药市场 - 新型冠状病毒（COVID-19）大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章全球非处方止痛药市场：依药物类别（2019-2031）

• 非类固醇消炎剂(NSAID)
• 局部麻醉剂
• 乙酰胺酚
• 水杨酸盐
• 其他的

第六章全球非处方止痛药市场：依给药途径（2019-2031）

• 口服
• 局部的
• 其他的

第七章全球非处方止痛药市场：依剂型分类（2019-2031）

• 锭剂/胶囊
• 液体
• 奶油
• 凝胶
• 其他的

第8章全球非处方止痛药市场：依通路划分（2019-2031）

• 院内药房
• 零售药房
• 网路药房

第9章全球非处方止痛药市场，依地区（2019-2031）

• 拉丁美洲
• 欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争格局

• 公司简介
  • Johnson &Johnson
  • Pfizer Inc.
  • Bayer AG
  • GlaxoSmithKline plc
  • Sanofi SA
  • Reckitt Benckiser Group plc
  • Novartis AG
  • Perrigo Company plc
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Alkem Laboratories Ltd.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Lupin Limited
  • Aurobindo Pharma Limited

第十一章分析师建议

• Wheel of Fortune
• 分析师观点
• Coherent Opportunity Map（COM）

第十二章参考文献与调查方法

• 参考
• 调查方法

The global over the counter pain medication market is estimated to be valued at USD 27.12 Bn in 2024 and is expected to reach USD 35.50 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.

Figure. Over The Counter Pain Medication Market Share (%), By Region 2024

The global over the counter pain medication market has witnessed substantial growth over the past decade owing to rising incidence of health conditions such as arthritis, back pain, and other muscular skeletal disorders across the world. Easy availability of pain relief drugs without prescription coupled with growing preference for self-medication over doctor visits has boosted the market growth. Furthermore, aging population profile in developed nations which are more vulnerable to chronic pain has augmented demand. Various pharmaceutical companies are launching new products with improved efficacy and minimal side effects to tap the lucrative prospects.

Market Dynamics:

The global over the counter pain medication market is primarily driven by rising geriatric population base, increasing prevalence of lifestyle induced diseases, and growing instances of minor injuries and discomforts which do not require immediate medical intervention. However, stringent regulatory framework surrounding self-medication especially in developed countries poses challenge to smooth business operations. Moreover, availability of alternative traditional pain relief therapies also impedes the market growth to some extent. On the bright side, growing health awareness and e-commerce penetration in developing regions have opened new revenue streams. Ongoing research & development towards developing advanced drug delivery systems is creating novel opportunities in the market.

Key Features of the Study:

This report provides in-depth analysis of the global over-the-counter pain medication market, and provides market size (USD billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global over-the-counter pain medication market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Johnson & Johnson, Pfizer, Bayer, GlaxoSmithKline, Taisho Pharmaceuticals, and Nestle

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global over-the-counter pain medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global over-the-counter pain medication market.

Detailed Segmentation

• By Drug Class
  • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  • Local Anaesthetics
  • Acetaminophen
  • Salicylates
  • Others
• By Route of Administration
  • Oral
  • Topical
  • Others
• By Dosage Form
  • Tablets/Capsules
  • Liquids
  • Creams
  • Gels
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Johnson & Johnson
  • Pfizer Inc.
  • Bayer AG
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Reckitt Benckiser Group plc
  • Novartis AG
  • Perrigo Company plc
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Alkem Laboratories Ltd.
  • Cipla Ltd.
  • Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Lupin Limited
  • Aurobindo Pharma Limited

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Dosage Form
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Over The Counter Pain Medication Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Over The Counter Pain Medication Market, By Drug Class, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Local Anaesthetics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Acetaminophen
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Salicylates
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Over The Counter Pain Medication Market, By Route of Administration, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Topical
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Over The Counter Pain Medication Market, By Dosage Form, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Tablets/Capsules
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Liquids
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Creams
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Gels
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Over The Counter Pain Medication Market, By Distribution Channel, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Over The Counter Pain Medication Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

• Company Profiles
  • Johnson & Johnson
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
  • Bayer AG
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Reckitt Benckiser Group plc
  • Novartis AG
  • Perrigo Company plc
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Alkem Laboratories Ltd.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Lupin Limited
  • Aurobindo Pharma Limited

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact